Study of circumferential resection margin in patients with middle and lower rectal carcinoma

World Journal of Gastroenterology

Volumn 13, Issue 24, 2007, Pages 3380-3383

  Wu, Ze Yu ^a   Wan, Jin ^a   Li, Jing Hua ^b   Zhao, Gang ^a   Peng, Lin ^a   Yao, Yuan ^a   Du, Jia Lin ^a   Liu, Quan Fang ^a   Wang, Zhi Du ^a   Huang, Zhi Ming ^a   Lin, Hua Huan ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Circumferential resection margin; Middle and lower rectal carcinoma; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; RECTUM CARCINOMA; RECTUM RESECTION; SURVIVAL RATE;

EID: 34447317223     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i24.3380     Document Type: Article

References (15)

1. Radice E, Dozois RR. Locally recurrent rectal cancer. Dig Surg 2001; 18: 355-362
2. Piso P, Dahlke MH, Mirena P, Schmidt U, Aselmann H, Schlitt HJ, Raab R, Klempnauer J. Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients. J Surg Oncol 2004; 86: 115-121
3. Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, Abbott CR, Scott N, Finan PJ, Johnston D, Quirke P. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-457
4. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356: 93-96
5. Temple WJ, Saettler EB. Locally recurrent rectal cancer: role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence. J Surg Oncol 2000; 73: 47-58
6. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-899
7. Wan J, Wu ZY, Du JL, Yao Y, Wang ZD, Lin HH, Luo XL, Zhang W. Mesorectal metastasis of middle and lower rectal cancer. Zhonghua Waike Zazhi 2006; 44: 894-896
8. Hermanek P, Junginger T. The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol 2005; 9: 193-199; discussion 199-200
9. Tekkis PP, Heriot AG, Smith J, Thompson MR, Finan P, Stamatakis JD. Comparison of circumferential margin involvement between restorative and nortrestorative resections for rectal cancer. Colorectal Dis 2005; 7: 369-374
10. Luna-Perez P, Bustos-Cholico E, Alvarado I, Maffuz A, Rodriguez-Ramirez S, Gutierrez de la Barrera M, Labastida S. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection. J Surg Oncol 2005; 90: 20-25
11. Hall NR, Finan PJ, al-Jaberi T, Tsang CS, Brown SR, Dixon MF, Quirke P. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 1998; 41: 979-983
12. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002; 26: 350-357
13. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-334
14. Mawdsley S, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Osborne M, Livingstone JI, MacDonald P, Mitchell IC, Meyrick-Thomas J, Northover JM, Windsor A, Novell R, Wallace M. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 2005; 63: 745-752
15. Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. J Am Coll Surg 2006; 203: 684-691